To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene C9orf16TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
182 supporting clones for gene C9orf16 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB493059 hypothalamus .a 1 to 456 1 to 456   tiling clone,   456/458
(99 %)
3 diff
(99.4 %id)
TI_57216944   .a 62 to 662 26 to 630       605/631
(95 %)
16 diff
(97.5 %id)
BI755420 brain .a 67 to 662 1 to 600       600/601
(99 %)
11 diff
(98.2 %id)
NM_024112.3   .a 67 to 779 1 to 713   RefSeq, AAA   713/713
(100 %)
0 diff
(100 %id)
CN360249 embryonic stem cells, cell lines H1, H7, andH9 .a 68 to 291 1 to 224       224/224
(100 %)
0 diff
(100 %id)
BM010618 amelanotic melanoma, cell line, skin .a 83 to 691 1 to 614       614/618
(99 %)
13 diff
(97.9 %id)
TI_59385452   .a 83 to 691 59 to 672       614/618
(99 %)
13 diff
(97.9 %id)
BM550794 amelanotic melanoma, cell line, skin .a 84 to 774 1 to 691   AAA   691/691
(100 %)
0 diff
(100 %id)
BM915599 amelanotic melanoma, cell line, skin .a 85 to 774 1 to 690   AAA   690/690
(100 %)
0 diff
(100 %id)
BU172797 eye, retinoblastoma .a 88 to 775 36 to 723       688/934
(73 %)
8 diff
(99.2 %id)
BF527926 anaplastic oligodendroglioma with 1p/19qloss, brain .a 89 to 634 1 to 543       543/543
(100 %)
6 diff
(98.9 %id)
CN360251 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 90 to 653 1 to 564       564/564
(100 %)
0 diff
(100 %id)
BM920182 pooled pancreas and spleen .a 90 to 779 1 to 690   tiling clone,   690/690
(100 %)
0 diff
(100 %id)
BI819858 pooled brain, lung, testis .a 91 to 774 1 to 681   AAA   681/681
(100 %)
10 diff
(98.6 %id)
CR979282 T-Lymphocytes .a 91 to 629 1 to 539       539/548
(98 %)
10 diff
(98.2 %id)
TI_57202952   .a 93 to 775 65 to 744   AAA   680/792
(85 %)
15 diff
(98.2 %id)
BI818356 pooled brain, lung, testis .a 96 to 752 1 to 657       657/795
(82 %)
12 diff
(98.5 %id)
TI_57196387   .a 96 to 752 92 to 748       657/886
(74 %)
18 diff
(98.0 %id)
BU602956 mixed (pool of 40 RNAs) .a 100 to 774 1 to 677       677/837
(80 %)
12 diff
(98.6 %id)
CD050422 embryonic trophoblasts, made from WA01 stemcells .a 101 to 774 18 to 691   AAA   674/691
(97 %)
7 diff
(99.0 %id)
BG493349 lung, mucoepidermoid carcinoma .a 102 to 213 1 to 118       118/118
(100 %)
9 diff
(92.4 %id)
BI547604 brain, hippocampus .a 104 to 774 6 to 675   AAA   670/675
(99 %)
12 diff
(98.3 %id)
TI_44168961   .a 104 to 774 84 to 753   tiling clone, AAA   670/753
(88 %)
12 diff
(98.5 %id)
BU182415 melanotic melanoma, skin .a 105 to 776 1 to 676       672/954
(70 %)
3 diff
(99.7 %id)
CR997925 T-Lymphocytes .a 111 to 636 1 to 526       526/529
(99 %)
6 diff
(98.9 %id)
BI760215 pooled colon, kidney, stomach .a 117 to 761 1 to 643       643/834
(77 %)
30 diff
(96.5 %id)
BU155835 melanotic melanoma, skin .a 118 to 772 1 to 656       656/883
(74 %)
2 diff
(99.8 %id)
TI_57148049   .a 118 to 761 36 to 677   AAA   642/847
(75 %)
34 diff
(96.0 %id)
BG116002 duodenal adenocarcinoma, cell line, small intestine .a 119 to 771 1 to 653       653/673
(97 %)
17 diff
(97.5 %id)
BM017905 astrocytoma grade IV, cell line, brain .a 120 to 775 1 to 656       656/674
(97 %)
3 diff
(99.6 %id)
BP198376 adrenal gland .a 121 to 700 1 to 582       582/582
(100 %)
7 diff
(98.8 %id)
BG256407 embryonal carcinoma, cell line, testis .a 121 to 771 1 to 650   AAA   650/650
(100 %)
10 diff
(98.5 %id)
TI_59388483   .a 121 to 775 103 to 757       655/714
(91 %)
2 diff
(99.8 %id)
BP307146   .a 121 to 702 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
CR992244 T-Lymphocytes .a 121 to 769 1 to 649       649/649
(100 %)
0 diff
(100 %id)
BM758821 myeloma .a 121 to 282 1 to 162       162/162
(100 %)
1 diff
(99.4 %id)
CN360250 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 123 to 645 9 to 531       523/531
(98 %)
6 diff
(98.9 %id)
BF340914 brain, glioblastoma with EGFR amplification .a 123 to 731 26 to 634       609/634
(96 %)
13 diff
(98.0 %id)
BM760463 lymph node, stomach .a 123 to 264 1 to 142       142/142
(100 %)
0 diff
(100 %id)
CD675661 eye, lens .a 124 to 775 1 to 655       651/655
(99 %)
5 diff
(99.3 %id)
BM761869 lymph node, stomach .a 129 to 625 1 to 497       497/497
(100 %)
2 diff
(99.6 %id)
CT003195 T-Lymphocytes .a 132 to 770 1 to 639       639/639
(100 %)
1 diff
(99.9 %id)
BG255513 adenocarcinoma, cell line, Prostate .a 133 to 772 1 to 634   AAA   634/634
(100 %)
18 diff
(97.2 %id)
CD177368 embryonic trophoblasts, made from WA01 stemcells .a 134 to 772 19 to 657       639/684
(93 %)
8 diff
(98.9 %id)
CD248305 embryonic stem cells, WA01, passage 38 .a 134 to 774 23 to 663   AAA   641/663
(96 %)
5 diff
(99.3 %id)
BQ937566 leiomyosarcoma, uterus .a 134 to 775 1 to 642       642/696
(92 %)
1 diff
(99.9 %id)
BM791175 stomach .a 134 to 735 1 to 602       602/602
(100 %)
2 diff
(99.7 %id)
BM852599 stomach .a 135 to 567 1 to 433       433/433
(100 %)
2 diff
(99.6 %id)
BG282399 melanotic melanoma, skin .a 136 to 775 1 to 644       644/1019
(63 %)
19 diff
(98.2 %id)
BM740783 Ascites, stomach .a 136 to 639 1 to 504       504/504
(100 %)
1 diff
(99.9 %id)
BM761945 myeloma .a 137 to 702 1 to 566       566/566
(100 %)
0 diff
(100 %id)
AK315753 thymus .a 140 to 466 1 to 327       327/327
(100 %)
0 diff
(100 %id)
AI816209 brain, frontal lobe .a 140 to 499 1 to 360       360/360
(100 %)
0 diff
(100 %id)
DB154050 thymus .a 141 to 436 2 to 298   capped   297/297
(100 %)
1 diff
(99.7 %id)
BG337357 leiomyosarcoma cell line, uterus .a 142 to 775 1 to 632       632/869
(72 %)
9 diff
(99.0 %id)
BG337291 leiomyosarcoma cell line, uterus .a 142 to 774 1 to 634   AAA   634/634
(100 %)
4 diff
(99.4 %id)
BU543200 carcinoma, cell line, Prostate .a 142 to 772 1 to 631       631/949
(66 %)
3 diff
(99.7 %id)
TI_57201107   .a 143 to 774 48 to 675   AAA   628/675
(93 %)
7 diff
(99.0 %id)
BM710475 eye, RPE and Choroid .a 143 to 759 1 to 616       616/616
(100 %)
3 diff
(99.6 %id)
BM716311 eye, RPE and Choroid .a 143 to 564 1 to 424       424/429
(98 %)
4 diff
(99.1 %id)
TI_151749598   .a 143 to 774 717 to 86   AAA   632/952
(66 %)
0 diff
(100 %id)
TI_227714792   .a 144 to 774 709 to 79   AAA   631/1020
(61 %)
2 diff
(99.9 %id)
CR999710 T-Lymphocytes .a 145 to 765 1 to 621       621/621
(100 %)
0 diff
(100 %id)
TI_57216787   .a 147 to 735 80 to 667       588/822
(71 %)
9 diff
(99.0 %id)
AW630215 2 pooled high-grade transitional celltumors, genitourinary tract .a 148 to 570 1 to 423       423/423
(100 %)
0 diff
(100 %id)
BG495459 lung, mucoepidermoid carcinoma .a 149 to 770 1 to 607       607/873
(69 %)
48 diff
(94.6 %id)
CR979445 T-Lymphocytes .a 149 to 660 1 to 512       512/513
(99 %)
1 diff
(99.9 %id)
DB475255 hippocampus .a 150 to 614 1 to 465       465/465
(100 %)
2 diff
(99.6 %id)
CA390751 eye, RPE/choroid .a 153 to 774 1 to 622   AAA   622/622
(100 %)
0 diff
(100 %id)
BI756695 brain .a 153 to 735 1 to 582       582/737
(78 %)
3 diff
(99.6 %id)
CD674307 eye, lens .a 156 to 587 1 to 432       432/432
(100 %)
0 diff
(100 %id)
CN360247 embryonic stem cells, DMSO-treated H9 cellline .a 157 to 772 1 to 616       616/616
(100 %)
5 diff
(99.2 %id)
CR975370 T-Lymphocytes .a 157 to 675 1 to 517       517/533
(96 %)
5 diff
(99.1 %id)
EL947047 eyeball .a 159 to 767 1 to 607       607/607
(100 %)
13 diff
(97.9 %id)
BF347241 anaplastic oligodendroglioma with 1p/19qloss, brain .a 159 to 774 1 to 612   AAA   612/612
(100 %)
6 diff
(99.1 %id)
BQ425248 leiomyosarcoma, uterus .a 161 to 774 1 to 613   AAA   613/613
(100 %)
2 diff
(99.7 %id)
BC001857 Muscle, rhabdomyosarcoma .a 163 to 774 1 to 612   available from MGC, AAA   612/612
(100 %)
0 diff
(100 %id)
BC008887 Muscle, rhabdomyosarcoma .a 163 to 777 1 to 615   available from MGC, AAA   615/615
(100 %)
0 diff
(100 %id)
DN991900 brain, whole brain .a 163 to 774 1 to 613   AAA   613/613
(100 %)
6 diff
(99.1 %id)
CR980069 T-Lymphocytes .a 165 to 775 1 to 611       611/611
(100 %)
0 diff
(100 %id)
BG164877 hypernephroma, cell line, Kidney .a 166 to 775 1 to 608       604/777
(77 %)
13 diff
(98.4 %id)
BI823867 pooled brain, lung, testis .a 166 to 774 1 to 607   AAA   607/607
(100 %)
2 diff
(99.7 %id)
CT001145 T-Lymphocytes .a 167 to 770 1 to 608       604/608
(99 %)
0 diff
(100 %id)
CR980040 T-Lymphocytes .a 169 to 775 1 to 607       607/613
(99 %)
2 diff
(99.7 %id)
BE884343 leiomyosarcoma, uterus .a 171 to 753 1 to 577       577/579
(99 %)
11 diff
(98.2 %id)
BE048062 brain, tumor, 5 pooled (see description) .a 174 to 447 1 to 274   fully sequenced,   274/274
(100 %)
0 diff
(100 %id)
CD386713 embryonic trophoblasts, made from WA01 stemcells .a 180 to 774 19 to 613   AAA   595/613
(97 %)
8 diff
(98.7 %id)
AW161534 brain, frontal lobe .a 181 to 668 1 to 488       488/488
(100 %)
0 diff
(100 %id)
BF036624 adenocarcinoma, ovary .a 181 to 773 1 to 589       589/589
(100 %)
12 diff
(98.0 %id)
BE295048 muscle, rhabdomyosarcoma .a 182 to 772 1 to 588       588/593
(99 %)
6 diff
(99.0 %id)
BE298286 muscle, rhabdomyosarcoma .a 184 to 774 1 to 610       610/610
(100 %)
30 diff
(95.1 %id)
BE730629 choriocarcinoma, placenta .a 185 to 774 1 to 587   AAA   587/587
(100 %)
7 diff
(98.9 %id)
BF969303 adrenal cortex carcinoma, cell line, adrenal gland .a 190 to 774 1 to 587   AAA   587/587
(100 %)
2 diff
(99.7 %id)
TI_57164263   .a 195 to 757 25 to 595       571/738
(77 %)
22 diff
(97.1 %id)
BG716800 brain, hypothalamus .a 202 to 772 1 to 571   AAA   571/571
(100 %)
5 diff
(99.2 %id)
BG709341 brain, hypothalamus .a 203 to 772 1 to 570   AAA   570/570
(100 %)
4 diff
(99.3 %id)
AA311468   .a 205 to 530 1 to 327       327/327
(100 %)
1 diff
(99.7 %id)
BI836771 pooled pancreas and spleen .a 205 to 757 1 to 561       561/704
(79 %)
17 diff
(97.6 %id)
BM708089 eye, RPE and Choroid .a 205 to 469 1 to 269   fully sequenced,   265/265
(100 %)
0 diff
(100 %id)
BM918749 pooled pancreas and spleen .a 206 to 774 14 to 582       569/626
(90 %)
7 diff
(98.9 %id)
CR989952 T-Lymphocytes .a 207 to 774 1 to 568   AAA   568/568
(100 %)
3 diff
(99.5 %id)
DB496142 hypothalamus .a 212 to 692 1 to 481       481/481
(100 %)
0 diff
(100 %id)
CV026096 mixed .a 215 to 465 1 to 251       251/345
(72 %)
1 diff
(99.8 %id)
AI885170 anaplastic oligodendroglioma, brain .a 215 to 774 564 to 1       560/564
(99 %)
1 diff
(99.9 %id)
AW269814 pooled .a 215 to 775 564 to 4       561/564
(99 %)
2 diff
(99.7 %id)
CN360248 embryonic stem cells, DMSO-treated H9 cellline .a 217 to 768 1 to 552       552/552
(100 %)
0 diff
(100 %id)
M62042   .a 218 to 652 1 to 448       448/472
(94 %)
24 diff
(95.0 %id)
BE733952 choriocarcinoma, placenta .a 228 to 775 1 to 548       548/548
(100 %)
1 diff
(99.9 %id)
BQ344613 nervous_tumor .a 238 to 493 1 to 258       258/259
(99 %)
13 diff
(95.0 %id)
BF998637 placenta_normal .a 258 to 530 1 to 273       273/273
(100 %)
4 diff
(98.6 %id)
CD742735 Alveolar Macrophage, lung .a 260 to 774 531 to 17   AAA   515/515
(100 %)
0 diff
(100 %id)
CN360246 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 266 to 779 1 to 513   AAA   513/513
(100 %)
3 diff
(99.5 %id)
CR998791 T-Lymphocytes .a 266 to 775 10 to 519   AAA   510/519
(98 %)
5 diff
(99.1 %id)
BM709209 eye, optic nerve .a 270 to 774 1 to 505       505/505
(100 %)
0 diff
(100 %id)
T35119 placenta .a 290 to 536 1 to 247       247/247
(100 %)
2 diff
(99.2 %id)
AW025494 Kidney .a 291 to 774 494 to 11   AAA   484/494
(97 %)
18 diff
(96.4 %id)
BE873711 large cell carcinoma, undifferentiated, lung .a 292 to 773 13 to 502       490/507
(96 %)
17 diff
(96.7 %id)
BE873803 large cell carcinoma, undifferentiated, lung .a 292 to 770 12 to 488       477/488
(97 %)
6 diff
(98.8 %id)
DB544079 hippocampus .a 300 to 772 1 to 473     Submitted on the opposite strand 473/474
(99 %)
2 diff
(99.6 %id)
DB567159 hypothalamus .a 307 to 772 1 to 466     Submitted on the opposite strand 466/466
(100 %)
0 diff
(100 %id)
AA155638 Pancreas .a 328 to 776 451 to 2       450/451
(99 %)
0 diff
(100 %id)
AW300975 colon, moderately differentiated adenocarcinoma .a 339 to 777 441 to 3       439/442
(99 %)
0 diff
(100 %id)
AI380992 B-cell, chronic lymphotic leukemia .a 341 to 775 437 to 3       435/437
(99 %)
0 diff
(100 %id)
DB564127 hypothalamus .a 347 to 772 1 to 428     Submitted on the opposite strand 428/428
(100 %)
15 diff
(96.5 %id)
BF746430 breast .a 349 to 688 352 to 15     Submitted on the opposite strand 338/353
(95 %)
0 diff
(100 %id)
AA878005 pharynx, squamous cell carcinoma .a 350 to 732 382 to 1       382/382
(100 %)
4 diff
(99.0 %id)
AI391659 B-cell, chronic lymphotic leukemia .a 356 to 774 430 to 12   AAA   419/419
(100 %)
2 diff
(99.6 %id)
BM711749 eye, human retina .a 357 to 774 1 to 417   fully sequenced, AAA   417/417
(100 %)
1 diff
(99.8 %id)
BP395803 pancreatic islet .a 390 to 767 1 to 377     Submitted on the opposite strand 377/377
(100 %)
1 diff
(99.8 %id)
BM665566 eye, human retina .a 402 to 774 389 to 17   fully sequenced, AAA   373/373
(100 %)
0 diff
(100 %id)
EH352537   .a 410 to 489 1 to 80       80/80
(100 %)
0 diff
(100 %id)
AI863366 brain, tumor, 5 pooled (see description) .a 417 to 774 373 to 16   fully sequenced, AAA   358/358
(100 %)
1 diff
(99.8 %id)
AI937209 anaplastic oligodendroglioma, brain .a 418 to 775 358 to 1       358/358
(100 %)
0 diff
(100 %id)
AI299211 carcinoid, lung .a 431 to 776 360 to 15   AAA   346/346
(100 %)
2 diff
(99.5 %id)
AI539424 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 431 to 711 416 to 136   AAA   281/405
(69 %)
0 diff
(100 %id)
BU731943 eye, RPE and Choroid .a 439 to 774 354 to 19   fully sequenced, AAA   336/336
(100 %)
0 diff
(100 %id)
AW105679 ovary, tumor, 5 pooled (see description) .a 445 to 775 339 to 8       332/346
(95 %)
0 diff
(100 %id)
AI523564 B-cell, chronic lymphotic leukemia .a 459 to 774 333 to 18   AAA   316/316
(100 %)
7 diff
(97.8 %id)
AA028132 uterus .a 468 to 775 322 to 9       314/322
(97 %)
0 diff
(100 %id)
EC542614 Prostate .a 474 to 591 1 to 118       118/118
(100 %)
4 diff
(96.7 %id)
AI369758 anaplastic oligodendroglioma, brain .a 476 to 774 325 to 27   AAA   299/299
(100 %)
11 diff
(96.4 %id)
AA897392 pooled .a 481 to 775 296 to 3       294/296
(99 %)
0 diff
(100 %id)
AA398406   .a 483 to 774 292 to 1     Submitted on the opposite strand 292/292
(100 %)
0 diff
(100 %id)
AW450134   .a 487 to 774 305 to 18   AAA   288/289
(99 %)
5 diff
(98.3 %id)
AA886795 Kidney .a 515 to 779 279 to 18   AAA   262/262
(100 %)
3 diff
(98.9 %id)
AI472820 pooled .a 546 to 774 244 to 16   AAA   229/229
(100 %)
2 diff
(99.2 %id)
AA865340 pooled germ cell tumors .a 550 to 777 266 to 44   AAA   223/223
(100 %)
9 diff
(96.0 %id)
AA904283 lung, small cell carcinoma .a 556 to 774 260 to 43   AAA   218/218
(100 %)
2 diff
(99.1 %id)
AI609658 brain, tumor, 5 pooled (see description) .a 562 to 777 259 to 44       216/259
(83 %)
0 diff
(100 %id)
DB070700 testis .b-u 1 to 504 2 to 505   tiling clone, capped   504/504
(100 %)
1 diff
(99.9 %id)
DB221757 trachea .b-u 8 to 568 2 to 563   capped   562/562
(100 %)
3 diff
(99.5 %id)
DA124023 cerebellum .b-u 28 to 562 2 to 536   capped   535/535
(100 %)
1 diff
(99.9 %id)
BM564568 duodenal adenocarcinoma, cell line, small intestine .b-u 46 to 781 5 to 741 A70P G124A tiling clone, AAA   737/741
(99 %)
12 diff
(98.4 %id)
DA238210 brain .b-u 67 to 568 2 to 503   tiling clone, capped   502/502
(100 %)
1 diff
(99.9 %id)
AW075403 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .b-u 360 to 786 426 to 1   tiling clone,   426/426
(100 %)
4 diff
(99.1 %id)
DB132805 thymus .b-u 676 to 1205 2 to 548   tiling clone, capped   547/547
(100 %)
11 diff
(98.0 %id)
DA054129 cerebellum .b-u 743 to 1251 2 to 529   tiling clone, capped   528/528
(100 %)
9 diff
(98.3 %id)
AU128110   .b-u 771 to 1153 9 to 395   capped   387/405
(95 %)
8 diff
(98.1 %id)
AK022885   .b-u 790 to 3616 28 to 2857   tiling clone, available from FLJ,   2830/2830
(100 %)
9 diff
(99.7 %id)
DA287984 corpus callosum .b-u 1600 to 2164 2 to 566   capped   565/565
(100 %)
3 diff
(99.5 %id)
AI884648 anaplastic oligodendroglioma, brain .b-u 1655 to 2174 1 to 520     Submitted on the opposite strand 520/520
(100 %)
2 diff
(99.7 %id)
BQ345836 nervous_tumor .b-u 2662 to 2914 252 to 4       249/278
(89 %)
0 diff
(100 %id)
BQ230080 embryonal carcinoma, cell line, testis .b-u 2677 to 3567 924 to 25     Submitted on the opposite strand 900/925
(97 %)
0 diff
(100 %id)
BX281321 embryonal carcinoma, cell line, testis .b-u 3068 to 3567 500 to 1     Submitted on the opposite strand 500/500
(100 %)
0 diff
(100 %id)
BM996050 lung, Metastatic Chondrosarcoma .b-u 3080 to 3618 555 to 17   tiling clone, AAA   539/539
(100 %)
0 diff
(100 %id)
AU150425   .b-u 3108 to 3614 505 to 3       503/506
(99 %)
0 diff
(100 %id)
CR601282 Neuroblastoma Cot 25-normalized .c 1 to 1581 5 to 1585 exact tiling clone,   1585/1585
(100 %)
0 diff
(100 %id)
AL526128.
matches multiple genes
brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 1 to 861 5 to 871   fully sequenced, also hits gene HDGFRP3 871/871
(100 %)
22 diff
(97.5 %id)
BQ058433 lymph, lymphoma, cell line .c 7 to 928 1 to 932       932/1024
(91 %)
25 diff
(97.6 %id)
BI916570 brain .c 33 to 664 1 to 631       631/635
(99 %)
2 diff
(99.7 %id)
TI_57240035   .c 33 to 664 32 to 662       631/666
(94 %)
7 diff
(99.0 %id)
AK311245 subthalamic nucleus .c 72 to 901 1 to 830       830/830
(100 %)
3 diff
(99.7 %id)
DC338496 subthalamic nucleus .c 72 to 585 1 to 514       514/514
(100 %)
2 diff
(99.7 %id)
BQ371463 prostate_normal .c 458 to 849 7 to 398       392/398
(98 %)
6 diff
(98.5 %id)
AA323713 brain, cerebellum .c 547 to 827 1 to 281       281/281
(100 %)
1 diff
(99.7 %id)
BG116628 duodenal adenocarcinoma, cell line, small intestine .c 618 to 1379 16 to 765       750/863
(86 %)
35 diff
(96.0 %id)
BU528124 epidermoid carcinoma, cell line, lung .c 659 to 1576 27 to 950 T72D Q73P P74T C75L L76P ...     924/950
(97 %)
26 diff
(97.3 %id)
BX451362 neuroblastoma .c 802 to 1607 1 to 813 exact     813/813
(100 %)
17 diff
(98.0 %id)
AL562618.
matches multiple genes
brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 831 to 1577 759 to 6 P5L N7B T12Y P13S C14M ... fully sequenced, also hits gene HDGFRP3 754/759
(99 %)
21 diff
(97.3 %id)
AA339121 brain .c 944 to 1125 188 to 7     Submitted on the opposite strand 182/188
(96 %)
0 diff
(100 %id)
BF435766 pooled .c 1104 to 1610 507 to 1 P63X L79X S81F     507/507
(100 %)
2 diff
(99.7 %id)
AI453567 pooled .c 1107 to 1610 505 to 1 T70N T72D Q73P P74T C75L ... tiling clone,   505/505
(100 %)
2 diff
(99.7 %id)
BM700399 eye, lens .d 1 to 573 1 to 573 exact tiling clone,   573/573
(100 %)
5 diff
(99.2 %id)
CV569661 cornea, eye .d 219 to 751 1 to 533   tiling clone,   533/533
(100 %)
1 diff
(99.9 %id)
BM670508 eye, lens .d 578 to 950 391 to 19   tiling clone, AAA   373/373
(100 %)
1 diff
(99.8 %id)
BM687109 eye, optic nerve .e 1 to 354 1 to 353   tiling clone, fully sequenced,   353/353
(100 %)
4 diff
(98.9 %id)
BU727556 eye, optic nerve .e 324 to 622 317 to 19 P45X tiling clone, fully sequenced, AAA   299/299
(100 %)
0 diff
(100 %id)
AA887745 colon, colon tumor RER+ Gene C9orf16, variant not shown       AAA Suspected internal deletion, this clone was ignored    
AI884687 anaplastic oligodendroglioma, brain Gene C9orf16, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b-u, .c, .d, .e Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes I